Novanta (NOVT) Cash & Equivalents (2010 - 2026)

Novanta has reported Cash & Equivalents for 17 years, with the latest figure at $388.8 million in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents rose 266.64% year-over-year to $388.8 million; the trailing twelve-month figure through Apr 2026 stood at $388.8 million (up 266.64% YoY), and the FY2025 full-year result was $380.9 million, up 234.13% from the prior year.
• Cash & Equivalents for Q2 2026 stood at $388.8 million, up from $380.9 million in the prior quarter.
• The five-year high for Cash & Equivalents was $388.8 million in Q2 2026, with the low at $76.0 million in Q3 2023.
• Historically, Cash & Equivalents has averaged $130.1 million across 5 years, with a median of $98.8 million in 2022.
• Annual changes were most pronounced in 2022 — Cash & Equivalents retreated 24.93% — and 2026, when it soared 266.64%.
• Novanta's Cash & Equivalents stood at $100.1 million in 2022, then gained by 4.94% to $105.1 million in 2023, then climbed by 8.51% to $114.0 million in 2024, then surged by 234.13% to $380.9 million in 2025, then climbed by 2.08% to $388.8 million in 2026.
• The last three Cash & Equivalents figures came in at $388.8 million (Q2 2026), $380.9 million (Q4 2025), and $89.2 million (Q3 2025), per Business Quant data.